그레일 (GRAL) 주가

그레일(GRAL)는 NASDAQ에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $80.77 (+1.03%), 시가총액 $2.60B, 52주 최저~최고 $31.42 ~ $116.06.

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal r

핵심 지표

• 현재가: $80.77 (+1.03%)
• 시가총액: $2.60B
• 52주 최저~최고: $31.42 ~ $116.06
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NASDAQ

그레일의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

그레일 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3.5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.06
• 순이익률: -2.53%
• 영업이익률: -3.33%

자주 묻는 질문